BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24311719)

  • 1. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
    Diani-Moore S; Ma Y; Gross SS; Rifkind AB
    Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.
    Labitzke EM; Diani-Moore S; Rifkind AB
    Arch Biochem Biophys; 2007 Dec; 468(1):70-81. PubMed ID: 17959137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic cytochrome P450-dependent arachidonic acid epoxygenation in diverse avian orders: regioisomer selectivity and immunochemical comparison of the TCDD-induced P450s to CYP1A4 and 1A5.
    Gilday D; Bellward GD; Sanderson JT; Janz DM; Rifkind AB
    Toxicol Appl Pharmacol; 1998 May; 150(1):106-16. PubMed ID: 9630459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
    Gross GJ; Gauthier KM; Moore J; Falck JR; Hammock BD; Campbell WB; Nithipatikom K
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2838-44. PubMed ID: 18441205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes: evidence for species-specific differences in responses.
    Lee CA; Lawrence BP; Kerkvliet NI; Rifkind AB
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):1-11. PubMed ID: 9875294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic acid metabolism in the marine fish Stenotomus chrysops (Scup) and the effects of cytochrome P450 1A inducers.
    Schlezinger JJ; Parker C; Zeldin DC; Stegeman JJ
    Arch Biochem Biophys; 1998 May; 353(2):265-75. PubMed ID: 9606961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes.
    Amruthesh SC; Boerschel MF; McKinney JS; Willoughby KA; Ellis EF
    J Neurochem; 1993 Jul; 61(1):150-9. PubMed ID: 8515261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of CYP1A and cyp2-mediated arachidonic acid epoxygenation and suppression of 20-hydroxyeicosatetraenoic acid by imidazole derivatives including the aromatase inhibitor vorozole.
    Diani-Moore S; Papachristou F; Labitzke E; Rifkind AB
    Drug Metab Dispos; 2006 Aug; 34(8):1376-85. PubMed ID: 16714371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hepatocytes as the major locus of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1-related P450s, TCDDAA and TCDDAHH, in chick embryo liver.
    Paroli L; Lee C; Rifkind AB
    Drug Metab Dispos; 1994; 22(6):962-8. PubMed ID: 7895616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
    Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
    Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels.
    Campbell WB; Deeter C; Gauthier KM; Ingraham RH; Falck JR; Li PL
    Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1656-64. PubMed ID: 11959628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
    Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase: a new target for cardioprotection.
    Gross GJ; Nithipatikom K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
    Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
    Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids.
    Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
    Am J Physiol; 1999 Nov; 277(5):H2098-108. PubMed ID: 10564166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of cytochrome P450 monooxygenase and lipoxygenase pathway products by heart fatty acid-binding protein.
    Widstrom RL; Norris AW; Spector AA
    Biochemistry; 2001 Jan; 40(4):1070-6. PubMed ID: 11170430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.